Research progress on the mechanisms of active constituents of Angelica dahurica in the treatment of migraine and related novel formulations
- VernacularTitle:白芷治疗偏头痛的有效成分作用机制及相关新型制剂研究进展
- Author:
Zicheng ZHAO
1
;
Jin HAN
1
;
Yongkang SUN
2
;
Yijun WU
1
;
Yanbo SONG
3
;
Yilong SUN
1
;
Xinzhi WANG
2
Author Information
1. Encephalopathy Center,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450099,China;The First Clinical Medical College,Henan University of Chinese Medicine,Zhengzhou 450046,China
2. Encephalopathy Center,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450099,China;Henan Collaborative Innovation Center for Prevention and Treatment of Major Diseases by Integrated Chinese and Western Medicine,Zhengzhou 450046,China
3. Encephalopathy Center,The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450099,China;Institute for Brain Disorders,Henan Academy of Chinese Medical Sciences,Zhengzhou 451163,China
- Publication Type:Journal Article
- Keywords:
Angelica dahurica;
Migraine;
coumarins;
volatile oils;
aliphatic compounds;
calcitonin gene-related peptide;
novel formulations
- From:
China Pharmacy
2026;37(21):2900-2904
- CountryChina
- Language:Chinese
-
Abstract:
Migraine is a prevalent primary headache disorder in clinical practice. Angelica dahurica is a frequently used traditional Chinese medicine for migraine management. This review summarizes the research progress on bioactive constituents, pharmacological mechanisms, and novel formulations of A. dahurica against migraine. The coumarins, volatile oils, aliphatic compounds and other components from A. dahuricae exert potential anti-migraine effects via multiple pathways, including modulating calcitonin gene-related peptide-related signaling, alleviating oxidative stress and neuroinflammation, regulating neurotransmitter levels and improving gut-brain axis function. Studies on novel formulations based on A. dahurica anti-migraine constituents mainly focus on non-oral administration routes such as nasal and transdermal delivery. Further investigations should focus on quality control of standardized extracts or defined component combinations, mechanistic validation, dose-effect relationship, pharmacokinetic-pharmacodynamic correlation, tissue distribution and safety evaluation, followed by randomized, double-blind, placebo-controlled exploratory clinical trials.